Novavax (NASDAQ: NVAX) has been one of the more promising COVID-19 vaccine stocks to invest in since the pandemic began. But while rival Moderna (NASDAQ: MRNA) has been generating billions in revenue from its vaccine, Novavax continues to wait for an Emergency Use Authorization in the U.S. market. There’s still […]

Open chat
thank you for contacting us, for more information
please chat